Recorded fact · drug.label_indication
drug.label_indication for valbenazine-tosylate|huntington-s-disease
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact ffa3992f resolves to.
The record
| Fact id | ffa3992f1e689a72251601d3 |
|---|---|
| Entity | drug: valbenazine-tosylate|huntington-s-disease |
| Field | drug.label_indication |
| Source | api.fda.gov |
| Read on | 2026-11-10T19:02:47.536Z |
| Source version | openfda-label-20260417 |
| Method | extract |
| Verification | verified |
| Licence | CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
The verifying quote
chorea associated with Huntington’s disease [see Clinical Studies ( 14.
Shown with dashes as hyphens. SHA-256 of the exact stored quote: f5b61f90a0ec268714099302eaa446a30306758b14e11018a266e4fd63882c29.
The value
{
"ingredient": "Valbenazine Tosylate",
"conditionId": "huntington-s-disease",
"conditionName": "Huntington's Disease",
"matchedAlias": "Huntington’s disease",
"context": "indication",
"brand": "INGREZZA",
"identifiedVia": "product_elements",
"extractor": 5,
"labelSetId": "4c970164-cafb-421f-9eb5-c226ef0a3417",
"labelEffectiveTime": "20260417",
"labelsRead": 1,
"labelsNaming": 1,
"registryEditionRoot": "1b44e76f5da1a417",
"meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}SHA-256 of the exact stored value: 94030ba5a34317f3cb758249a1f628fcbcf26be8e7e7e276c7d6954b25cbbd68.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.